Abstract:Tumor angiogenesis plays a pivotal role in the progress of tumor. Among the various endogenous angiogenic inhibitors discovered, the human plasminogen kringle 5 (K5) has been demonstrated to be a potential inhibitor of the proliferation and migration of vascular endothelial cells in vitro. The replication-incompetent adenovirus (Ad) vector Adeno-X-CMV-K5 (Ad-K5) (where CMV is cytomegalovirus) was constructed and its antiangiogenic effect was tested on vascular endothelial cell and tumor cell. For the construction, the K5 cDNA was fused in-frame with human plasminogen signal sequence and inserted into the eukaryotic expression vector pcDNA3 to form pcDNA3K5. The recombinant plasmid was subcloned into the shuttle plasmid pShuttle under the control of the constitutive CMV immediate-early promoter. The plasmid carrying the cDNA for K5 (pShuttleKS) was then recombined with the Adeno-X viral DNA and transformed into E. coli DH5alpha. The resultant recombinant plasmid pAd-K5 was transfected into human embryonic kidney (HEK) 293 cells with liposome. The adenovirus expressing human plasminogen kringle 5 (Ad-K5) was successfully packaged and propagated in 293 cells, as detected by the cytopathic effect (CPE) on the cells, and the viral titer in the supernatant was 5 x 10(8) pfu/mL by plaque assay. Both human umbilical vein endothelial cell line ECV304 and human breast carcinoma cell line MDA-MB-231 were infected with Ad-K5 and Ad-LacZ, which was used the negative control, and assayed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Compared with uninfected control and Ad-LacZ infected control, Ad-K5 infected group at 80 MOI (multiplicity of infection) significantly inhibited ECV304 proliferation; the difference between uninfected control and Ad-LacZ infected control was not significant. In contrast, there was no significant difference in the proliferation of MDA-MB-231 among all the treatments. In addition, the Ad-K5 at 100 MOI inhibited the differentiation and tube formation of ECV304 on ECMatrix gel. These results suggested that the recombinant replication-defective Adenovirus expressing human plasminogen kringle 5 inhibited the proliferation, differentiation and tube formation of ECV304 and had no effect on the proliferation of MDA-MB-231. Adenovirus mediated human plasminogen kringle 5 gene therapy may be a potential treatment of cancer through angiogenesis inhibition.

Construction of Recombinant Adenovirus Carrying Mutant Human Plasminogen Kringle 5 Gene and Expression of K5 Protein

Construction of Recombinant Adenovirus Carrying Kringle 5 Gene and Effects on the Survival of Pulmonary Carcinoma Bearing Mice

[Preparation and Functional Study of an Adenovirus Vector Expressing Human Plasminogen Kringle 5 Gene].

Construction,Expression and Purification of Human Plasminogen Kringle 5 Mutant Ⅰ in E.coli

Construction of Recombinant Human Plasminogen Kringle5 Baculovirus Vector and Secreted Expression in Myoblast

Construction of Recombinant Adenoviral Vector Expressing Cloned Human KCNE5 Gene

Construction, Expression, and Purification of Active Human Plasminogen Mutant GST-K5M5 from E.coli

Conruction of Recombinatn Human Plasminogen Kringle5 Baculovirus Vecotr and Secreted Expression in Myoblast

Cloning Construction and Purification of Recombinant Human Plasminogen Kringle 5 Gene

Optimal Expression and Activity Detection of Human Plasminogen Mutant Kringle 5 in E.coli

Human Plasminogen Kringle 5 Cdna Clone with Eukaryotic System and Identification of Its Expression Product

Construction and Expression of Eukaryotic Expression Vector for Recombinant Human Plasminogen Kringle 5 Gene

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

[A Deletion Mutant of Plasminogen Kringle 5 Inhibits Retinal Capillary Endothelial Cell Proliferation].

[Construction of Recombinant Adenovirus Vector of Mouse Keratinocyte Growth Factor].

Cloning and Construction of Adenovirus Expressing Human Angiopoietin-1 or Vascular Endothelial Growth Factor

Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization.

Cloning of connective tissue growth factor gene and construction of recombinant adenovirus vector Ad5-CTGF

Plasminogen Kringle 5 Deletion Mutant I Inhibits the Neovascularization and Growth of the Mouse Hepatocarcinoma

[Construction of Recombinant Adenovirus Vector of Calcitonin Gene-Related Peptide Gene and Transfection to Neonatal Rat Cardiomyocytes].

Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.